🇺🇸 FDA
Patent

US 8614082

Attenuation of encephalitogenic alphavirus and uses thereof

granted A61KA61K2039/5254A61K39/12

Quick answer

US patent 8614082 (Attenuation of encephalitogenic alphavirus and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5254, A61K39/12, A61P, A61P31/12